Nuvectis Pharma, Inc. (NVCT) SEC Filings — 2024
16 SEC filings for Nuvectis Pharma, Inc. (NVCT) in 2024.
Filings
- Nuvectis Pharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 5, 2024
- Nuvectis Pharma Files 8-K on Operations and Financials — 8-K · Nov 5, 2024
- Nuvectis Pharma Q3 2024 Update: Assets $19M, Liabilities $1.4M — 10-Q · Nov 5, 2024
- Nuvectis Pharma Files 8-K — 8-K · Aug 29, 2024
- Nuvectis Pharma Files 8-K on Operations and Financials — 8-K · Aug 6, 2024
- Nuvectis Pharma Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- Nuvectis Pharma Files 8-K on Security Holder Votes — 8-K · Jun 13, 2024
- Nuvectis Pharma Files 8-K on Operations and Financials — 8-K · May 7, 2024
- Nuvectis Pharma Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Nuvectis Pharma, Inc. Announces Annual Meeting of Stockholders on June 13, 2024 — DEF 14A · Apr 29, 2024
- Nuvectis Pharma Files 8-K on Financials — 8-K · Mar 5, 2024
- Nuvectis Pharma Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Nuvectis Pharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 28, 2024
- Pontifax VI G.P. L.P. Discloses 917,400 Share Stake in Nuvectis Pharma — SC 13G · Feb 6, 2024
- Poradosu Holds 8.7% Stake in Nuvectis Pharma — SC 13G/A · Feb 1, 2024
- Thomas Peters Discloses 5.2% Stake in Nuvectis Pharma — SC 13G/A · Jan 31, 2024